Gapping down
In reaction to disappointing earnings/guidance: TMST -10%
Select financial related names showing weakness: RBS -2.2%, BCS -1.1%, SAN -1%, DB -0.9%
Select China related names showing early weakness: JMEI -5.3%, TOUR -3.9%, JD -2.3%, QIHU -1.1%, SOHU -0.9%
Other news: RPTP -33.9% (announces topline results from the Phase 2b CyNCh study, which did not meet its primary endpoint of improving nonalcoholic steatohepatitis in children), BABA -3.7% (Barron's profiles cautious view on Alibaba), AMD -2.5% (following late day spike on Friday), YHOO -2% (in symp with BABA), MT -2% (weakness stemming from concerns of growth in China), GOLD -1.9% (still checking), FCX -1.1% (copper down 1% in pre-mkt)
Analyst comments: HRB -1.5% (downgraded to Neutral from Buy at BTIG Research), GFI -1.1% (downgraded to Neutral from Overweight at JP Morgan
)
In reaction to disappointing earnings/guidance: TMST -10%
Select financial related names showing weakness: RBS -2.2%, BCS -1.1%, SAN -1%, DB -0.9%
Select China related names showing early weakness: JMEI -5.3%, TOUR -3.9%, JD -2.3%, QIHU -1.1%, SOHU -0.9%
Other news: RPTP -33.9% (announces topline results from the Phase 2b CyNCh study, which did not meet its primary endpoint of improving nonalcoholic steatohepatitis in children), BABA -3.7% (Barron's profiles cautious view on Alibaba), AMD -2.5% (following late day spike on Friday), YHOO -2% (in symp with BABA), MT -2% (weakness stemming from concerns of growth in China), GOLD -1.9% (still checking), FCX -1.1% (copper down 1% in pre-mkt)
Analyst comments: HRB -1.5% (downgraded to Neutral from Buy at BTIG Research), GFI -1.1% (downgraded to Neutral from Overweight at JP Morgan
)